LXEO
Price
$3.95
Change
+$0.04 (+1.02%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
129.78M
55 days until earnings call
RGNX
Price
$7.86
Change
-$0.57 (-6.76%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
424.78M
37 days until earnings call
Interact to see
Advertisement

LXEO vs RGNX

Header iconLXEO vs RGNX Comparison
Open Charts LXEO vs RGNXBanner chart's image
Lexeo Therapeutics
Price$3.95
Change+$0.04 (+1.02%)
Volume$11.27K
Capitalization129.78M
REGENXBIO
Price$7.86
Change-$0.57 (-6.76%)
Volume$11.95K
Capitalization424.78M
LXEO vs RGNX Comparison Chart in %
Loading...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LXEO vs. RGNX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXEO is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2025
Stock price -- (LXEO: $3.91 vs. RGNX: $8.43)
Brand notoriety: LXEO and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXEO: 90% vs. RGNX: 221%
Market capitalization -- LXEO: $129.78M vs. RGNX: $424.78M
LXEO [@Biotechnology] is valued at $129.78M. RGNX’s [@Biotechnology] market capitalization is $424.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXEO’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • LXEO’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXEO’s TA Score shows that 6 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • LXEO’s TA Score: 6 bullish, 4 bearish.
  • RGNX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than RGNX.

Price Growth

LXEO (@Biotechnology) experienced а -0.76% price change this week, while RGNX (@Biotechnology) price change was -9.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.37%. For the same industry, the average monthly price growth was +28.11%, and the average quarterly price growth was +12.64%.

Reported Earning Dates

LXEO is expected to report earnings on Aug 18, 2025.

RGNX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($425M) has a higher market cap than LXEO($130M). RGNX YTD gains are higher at: 9.056 vs. LXEO (-39.818). LXEO has higher annual earnings (EBITDA): -107.14M vs. RGNX (-122.44M). RGNX has more cash in the bank: 268M vs. LXEO (99.8M). LXEO has less debt than RGNX: LXEO (9.4M) vs RGNX (79.8M). RGNX has higher revenues than LXEO: RGNX (157M) vs LXEO (0).
LXEORGNXLXEO / RGNX
Capitalization130M425M31%
EBITDA-107.14M-122.44M88%
Gain YTD-39.8189.056-440%
P/E RatioN/AN/A-
Revenue0157M-
Total Cash99.8M268M37%
Total Debt9.4M79.8M12%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LXEORGNX
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
85%
Bullish Trend 13 days ago
75%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AQGIX11.750.07
+0.60%
AQR Global Equity I
BCLPX8.65N/A
N/A
BlackRock Event Driven Equity Inv C
PSSPX25.26N/A
N/A
Principal SmallCap S&P 600 Index R5
ABIEX9.01N/A
N/A
AB Emerging Markets Multi-Asset I
SUGAX13.21N/A
N/A
Victory Pioneer Global Growth A

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with ARWR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
+1.28%
ARWR - LXEO
50%
Loosely correlated
+1.24%
COGT - LXEO
46%
Loosely correlated
+0.41%
BEAM - LXEO
43%
Loosely correlated
-0.30%
KOD - LXEO
43%
Loosely correlated
+0.28%
RGNX - LXEO
42%
Loosely correlated
-6.76%
More